Transfusion-transmitted HBV and HCV

Vox Sanguinis

Volumn 70, Issue , 1996, Pages 4-8

  Nishioka, Kusuya ^a  

^a NONE

Author keywords

Agglutination test; Blood screening; Hepatitis B; Hepatitis C; Post transfusion infection; Voluntary blood donation

Indexed keywords

AGGLUTINATION TEST; BLOOD DONOR; BLOOD TRANSFUSION; CONFERENCE PAPER; EPIDEMIOLOGY; HEPATITIS B; HEPATITIS C; HUMAN; JAPAN; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; PRIORITY JOURNAL; SCREENING; VIRUS CARRIER; VIRUS TRANSMISSION;

EID: 0029948783     PISSN: 00429007     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1423-0410.1996.tb01359.x     Document Type: Article

References (15)

1. International Agency for Research on Cancer: IARC Monographs on the evaluation of carcinogenic risks to humans. Volume 59 Hepatitis Viruses. Lyon IARC 1994.
2. Nishioka K. Epidemiological studies on hepatitis C virus infection; Detection, Prevention, Exposure and Prevention. Intervirology 1994; 37: 58-97
3. Nishioka K. How far have we come and where are we going? Pathogen oriented prevention of hepatocellular carcinoma in Japan, in Nishioka K, Suzuki H, Mishiro S, Oda T (ed): Viral Hepatitis and Liver Disease. Tokyo, Springer, 1994; pp. 12-15
4. Katayama T: Report on post-transfusion hepatitis ; in Mayumi M (ed): Reports of the Japanese Red Cross Research Group. 1986; pp. 7-16 .
5. Mayumi M, Okochi K, Nishioka K: Detection of Australia antigen by means of immune adherence hemagglutination test. Vox Sang 1971; 20: 178-181.
6. Juji T and Yokochi T: Hemagglutination technique with erythrocytes coated with specific antibody for detection of Australia antigen. Japan J exp. Med 1969; 39: 615-620.
7. Iizuka H, Ohara K, Ishijima A, Sato K, Tsuda F, Okamoto H, Miyakawa Y, Mayumi M: Correlation between anti HBc titers and HBV DNA in blood units without detectable HBsAg. Vox Sang 1992; 63: 107-111.
8. Japanese Red Cross Non-A Non-B Hepatitis Research Group: Effect of screening for hepatitis C virus antibody and hepatitis B virus core antibody on the incidence of post transfusion hepatitis. Lancet 1991; 338: 1040-1041.
9. Watanabe J, Matsumoto C, Fujimura K. Shimada T, Yoshizawa H, Okamoto H, Iizuka H, Tango T, Ikeda H, Endo N, Mazda T, Nojiri T, Aoyama K, Kanemitsu K, Yamano H, Mizui M, Yokoishi F, Yokunaga K, Nishioka K. Predictive value of screening test for persistent hepatitis C virus infection evidenced by viraemia. Japanese Experience. Vox Sang 1993; 65: 199-203
10. Mizui M, Moriya T, Yoshizawa H, Kondo M, Saito T, Imai M, Nishioka K. A novel agglutination method for screening of HIV and HCV reagents: Reduction of cost and time with high sensitivity. Vox Sang 1994; 67: 315-316
11. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Van Sant CL, Mushahwar IK. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc. Natl. Acad. Sci. USA. 1995; 92: 3401-3405
12. Simons JN, Leary TP, Dawson GJ, Pilot-Matias TJ, Muerhoff AS, Schlauder GG, Desai SM, Mushahwar IK. Isolation of novel virus-like sequences associated with human hepatitis. Nature Medicine 1995; 1:564-569
13. Kim JP and the HXV Collaborative Working Group. A new human hepatitis virus. US Japan hepatitis panel meeting (Abstract) 1995, 40.
14. Nanda SK, Ansari IH, Acharya SK, Jameel S, Panda SK. Protracted viremia during acute sporadic hepatitis E virus injection. Gastroenterology 1995; 108: 225-230
15. Yoshiba M, Okamoto H, Mishiro S. Detection of the GBV-C hepatitis virus genome in serum from patients with fulminant hepatitis of unknown aetiology. Lancet 1995; 346: 1131-1132